new_0222_0143|ZNTL|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0143|ZNTL|1|Zentalis Pharmaceuticals Inc Total Current Assets (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Inventories (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Net PP&E (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Total Liabilities (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Total Deposits (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Book Value (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Retained Earnings (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Treasury Stock (Quarterly) (USD)|Zentalis Pharmaceuticals Inc EV to Revenues|Zentalis Pharmaceuticals Inc EV to Earnings|Zentalis Pharmaceuticals Inc EV to Free Cash Flow|Zentalis Pharmaceuticals Inc EV to Assets (Quarterly)|Zentalis Pharmaceuticals Inc PS Ratio|Zentalis Pharmaceuticals Inc PE Ratio|Zentalis Pharmaceuticals Inc Price to Book Value|Zentalis Pharmaceuticals Inc PEG Ratio|Zentalis Pharmaceuticals Inc Debt to Equity Ratio|Zentalis Pharmaceuticals Inc Dividend Yield|Zentalis Pharmaceuticals Inc Shareholder Yield (TTM)|Zentalis Pharmaceuticals Inc Percent of Shares Outstanding Short|Zentalis Pharmaceuticals Inc Total Receivables (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Total Payables (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Return on Invested Capital|Zentalis Pharmaceuticals Inc Quality Ratio Score|Zentalis Pharmaceuticals Inc Momentum Score|Zentalis Pharmaceuticals Inc Beta (1Y)|Zentalis Pharmaceuticals Inc Sustainable Growth Rate (TTM)|Zentalis Pharmaceuticals Inc Institutional Investor Ownership Percentage|Zentalis Pharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|Zentalis Pharmaceuticals Inc Total Employees (Annual)|Zentalis Pharmaceuticals Inc EPS Diluted (Quarterly) (USD)|Zentalis Pharmaceuticals Inc SG&A Expense (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Shares Outstanding|Zentalis Pharmaceuticals Inc Repurchase of Capital Stock (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Ordinary Shares Number (Quarterly)|Zentalis Pharmaceuticals Inc Payout Ratio|Zentalis Pharmaceuticals Inc Quick Ratio (Quarterly)|Zentalis Pharmaceuticals Inc Normalized Diluted EPS (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Stock Buybacks (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Effective Tax Rate (TTM)|Zentalis Pharmaceuticals Inc Return on Equity|Zentalis Pharmaceuticals Inc Net Income (TTM) (USD)|Zentalis Pharmaceuticals Inc Revenue (TTM) (USD)|Zentalis Pharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Revenue (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Gross Profit (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Net Income (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Net Interest Income (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Price (USD)|Zentalis Pharmaceuticals Inc Total Return Price (USD)|Zentalis Pharmaceuticals Inc Enterprise Value (USD)|Zentalis Pharmaceuticals Inc 30-Day Average Daily Volume|Zentalis Pharmaceuticals Inc 1 Year Price Returns (Daily)|Zentalis Pharmaceuticals Inc Short Interest|Zentalis Pharmaceuticals Inc PE Ratio (Forward)|Zentalis Pharmaceuticals Inc PE Ratio (Forward 1y)|Zentalis Pharmaceuticals Inc PS Ratio (Forward)|Zentalis Pharmaceuticals Inc PS Ratio (Forward 1y)|Zentalis Pharmaceuticals Inc Quarterly EPS Estimates (USD)|Zentalis Pharmaceuticals Inc Quarterly Revenue Estimates (USD)|Zentalis Pharmaceuticals Inc Quarterly EPS Surprise|Zentalis Pharmaceuticals Inc Quarterly Revenue Surprise|Zentalis Pharmaceuticals Inc Quarterly Actual EPS (USD)|Zentalis Pharmaceuticals Inc Quarterly Actual Revenue (USD)|Zentalis Pharmaceuticals Inc Revenue Estimates for Current Fiscal Year (USD)|Zentalis Pharmaceuticals Inc Revenue Estimates for Next Fiscal Year (USD)|Zentalis Pharmaceuticals Inc Price Target (USD)|Zentalis Pharmaceuticals Inc Consensus Recommendation|Zentalis Pharmaceuticals Inc Price Target Num Estimates|Zentalis Pharmaceuticals Inc EPS Estimates for Current Fiscal Year (USD)|Zentalis Pharmaceuticals Inc EPS Estimates for Next Fiscal Year (USD)|Zentalis Pharmaceuticals Inc Research and Development Expense (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Reconciled Depreciation (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Non-Operating Interest Expense (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Land and Improvements (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Buildings and Improvements (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Other Properties (Quarterly) (USD)|Zentalis Pharmaceuticals Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0143|ZNTL|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0143|ZNTL|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0143|ZNTL|5|91.2857142857|91.2857142857||91.2857142857|91.2857142857|91.2857142857|91.2857142857|91.2857142857||91.2857142857|91.2857142857||||1.44725738397||||1.44444444444|||1.44725738397||15.2558139535|91.2857142857|91.2857142857|91.2857142857|||30.7142857143|30.6666666667|||91.4|102|91.4|91.4|38.3125||91.2857142857|||91.4|91.4444444444|91.2857142857||91.2857142857|||||91.4|91.4|91.375|1.44725738397|1.44725738397|1.44725738397|1.44719101124|1.43049327354|15.2558139535||||1.44117647059|91.3636363636|91.3636363636|91.3333333333||91.3333333333|91.3333333333|24.1111111111|27.125|16.275|9.57352941176|16.275|15.5|17.1315789474|91.4|91.4||||91.2857142857|91.2857142857||
new_0222_0143|ZNTL|6|7|7||7|7|7|7|7||7|7||||474||||414|||474||43|7|7|7|||7|9|||10|3|10|10|16||7|||10|9|7||7|||||10|10|8|474|474|474|445|223|43||||34|11|11|6||6|6|27|24|40|68|40|42|38|10|10||||7|7||
new_0222_0143|ZNTL|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0143|ZNTL|201903||||||||||||||||||||||||||||||||||18.058||-0.462|1.633||||||-0.462|||||||||-8.66|-8.343|0.074||||||||||||||||||||||||7.089|0.021|||||||
new_0222_0143|ZNTL|201906||||||||||||||||||||||||||||||||||18.058||-0.5798|1.946||||||-0.5818|||||||||-10.586|-10.47|||||||||||||||||||||||||8.689|0.024|||||||
new_0222_0143|ZNTL|201909||||||||||||||||||||||||||||||||||18.058||-0.6836|1.844||||||-0.6841|||||||||-12.571|-12.344|||||||||||||||||||||||||10.739|0.025|||||||
new_0222_0143|ZNTL|201912|68.891|67.246||2.836|12.536|160.766|14.897|145.869||-80.106|-82.993||||||||||||||0.14|4.289|2.887|||||||32.8743|62|-0.4413|3.036|||32.8743|||-0.4522||-0.0324||-45.663|||||-14.546|-14.506|||||||||||||||||||||||||11.869|0.041||||2.736|0.243||
new_0222_0143|ZNTL|202003|66.009|63.65||2.795|12.536|176.82|16.939|159.881||-95.903|-99.119||||-24.3731|||||||||2.3697|0.139|7.019|3.216|||||||34.5015||-0.4905|3.141|32.8743||34.5015|||-0.4905||-0.0222||-53.446|||||-16.235|-16.126|0.164|35.1|35.1|1154.0646|202555.1||817580|||||-0.47|0.0667|-512.766|-100|-2.88||0.2667||44|1.25|4|-1.9|-2.21|13.258|0.038||||2.677|0.271|52.22|
new_0222_0143|ZNTL|202006|238.481|233.191||2.571|12.536|19.292|15.567|3.725||213.224|-125.976||||-24.3148||||8.0801|||||6.7759|0.073|4.217|0.036|||||||34.353|75|-0.78|9.924|35.8781||35.8781|||-0.7824|-172.482|-0.0014||-69.833|||||-27.292|-26.857||48.02|48.02|1514.3764|280739.4||2431055|||||-0.495||-57.5758||-0.78||||45|1.25|5|-4.4733|-3.4567|17.452|0.038||||2.435|0.298|34.5|34.4
new_0222_0143|ZNTL|202009|372.736|367.436||2.396|12.536|27.4|23.906|3.494||341.055|-160.531||||-13.5321||||3.8929|||||5.1852|0.122|5.437|0.041|||||||37.959|110|-0.91|10.097|40.6145||40.6145|||-0.9123|-155.899|-0.0194||-92.044|||||-34.647|-34.555||32.69|32.69|985.03|140354.7333||2105958|||||-0.7567||-20.2638||-0.91||||44.8333|1.3333|6|-4.21|-3.5125|24.67|0.051||||2.285|0.291|39.59|50.96
new_0222_0143|ZNTL|202012|345.104|338.505||3.619|12.536|32.178|28.601|3.577||308.582|-200.834||||-20.7566||||6.9078|||||7.3271|0.417|9.071|0.041|||||||40.023|124|-1.01|10.724|41.0403||41.0403|||-1.0157|0.594|-0.3759||-117.841|||||-39.93|-40.303||51.94|51.94|1817.9232|505265.3||3007059|||||-0.94||-7.4468||-1.01||||50.2|1.4|5|-4.32|-4.365|29.521|0.033||||2.944|0.529|38.37|42.04
new_0222_0143|ZNTL|202103|306.354|298.381||3.409|12.536|35.715|32.797|2.918||268.386|-250.735||||-13.8748||||6.635|||||8.1355|1.663|8.943|0.041||||1.7189|||40.359||-1.24|11.953|41.0403||41.0403|||-1.24||-0.4207||-151.616|||||-50.248|-49.901|0.143|43.39|43.39|1506.6096|275307.1333|69.0028|3338818|||||-0.914||-35.6674||-1.24||||62|1.3333|6|-3.9275|-4.17|38.394|0.079||||2.95|0.545|59.32|55.85
new_0222_0143|ZNTL|202106|259.449|250.9||3.446|12.536|36.353|33.577|2.776||223.845|-305.309||||-14.7671||||9.8191|||||5.6968|1.48|8.833|0.041|||3|1.4238|||40.738||-1.34|10.362|41.3149||41.3149|||-1.3421||-0.3809||-179.333|||||-55.017|-54.574||53.2|53.2|1970.8167|349272.2333|10.7872|2353627|||||-1.1626||-15.2619||-1.34||||72.1429|1.2857|7|-4.7021|-5.239|44.77|0.119||||2.909|0.554|53.21|68.19
new_0222_0143|ZNTL|202109|377.565|366.791||5.391|3.736|41.085|39.415|1.67||393.432|-309.5||||-17.7563||||7.6558|||||5.5151|0.108|8.813|0.045|||8|2.2657|||44.609||-0.09|8.872|45.1985||45.1985|||-1.1764|-166.254|0.0192||-148.969|||||-11.189|-4.191||66.64|66.64|2645.801|302204.0333|103.8544|2492734|||||-1.2484||92.7909||-0.09||||75.4444|1.2222|9|-5.0275|-5.6719|53.998|0.137||||2.576|0.563|80.44|82.05
new_0222_0143|ZNTL|202112|||||||||||||||-23.1008||||9.6799|||||7.5905||||||9|3.2187||||||||||||||||||||||||84.06|84.06|3442.1533|288195.2333|61.8406|3438908||||715.5341|-1.3122|||||||6.1961|97.75|1.125|8|-3.9203|-5.4126||||||||57.08|47.66
new_0222_0143|ZNTL|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-1.4988|||||||||||||||||||||
new_0222_0143|ZNTL|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-1.567|||||||||||||||||||||
new_0222_0143|ZNTL|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-1.6145|||||||||||||||||||||
new_0222_0143|ZNTL|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-1.6547|||||||||||||||||||||